Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Malignant

Explore clinical trials studying Neoplasm Malignant. Study availability and eligibility vary by location and protocol.

37 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Malignant trial results

Completed

First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor

NCT01156870

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840002 Cincinnati, Ohio, United States
  • Investigational Site Number 840001 San Antonio, Texas, United States
  • Investigational Site Number 250001 Toulouse, France
  • Investigational Site Number 724002 Madrid, Spain
View Trial Details
Completed

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients

NCT01657214

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 392001 Kashiwa-Shi, Japan
  • Investigational Site Number 392004 Suita-Shi, Japan
  • Investigational Site Number 392002 Sunto-Gun, Japan
  • Investigational Site Number 392003 Takatsuki-Shi, Japan
View Trial Details
Completed

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

NCT01140607

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840014 La Jolla, California, United States
  • Investigational Site Number 840013 Loma Linda, California, United States
  • Investigational Site Number 840020 Washington D.C., District of Columbia, United States
  • Investigational Site Number 840016 Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Completed

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

NCT01673737

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840001 Boston, Massachusetts, United States
  • Investigational Site Number 840101 Boston, Massachusetts, United States
  • Investigational Site Number 840002 Houston, Texas, United States
  • Investigational Site Number 124001 Toronto, Canada
View Trial Details
Completed

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

NCT01455532

Conditions
Neoplasm Malignant, Neoplasms
Locations
  • Investigational Site Number 840002 Scottsdale, Arizona, United States
  • Investigational Site Number 840004 Los Angeles, California, United States
  • Investigational Site Number 840010 Augusta, Georgia, United States
  • Investigational Site Number 840007 St Louis, Missouri, United States
View Trial Details

Related conditions